An Open-label, Multi-center, Randomized, Phase II Study of the Safety, and Bioactivity of Two Dose Regimens of Subcutaneous Injections of ACTH Gel in Patients With Non-infectious Uveitis
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Corticotropin (Primary)
- Indications Uveitis
- Focus Adverse reactions
- Acronyms ACTHAR
- 25 Sep 2018 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
- 25 Sep 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2019.
- 25 Sep 2018 Status changed from not yet recruiting to recruiting.